1. Home
  2. /
  3. Venture Capital
  4. /
  5. Dr Jeanne Bolger, the...

News / Venture Capital

Dr Jeanne Bolger, the new Chair of AstriVax

27 September 2022
AstriVax has announced that Dr Jeanne Bolger will chair its Board of Directors as non-executive independent director. With over 35 years of management experience in the pharmaceutical industry, Dr Bolger offers invaluable expertise that will help AstriVax to continue to build its innovative vaccine technology platform and bring its first vaccines to the clinical development stage.

Download

Press Release
Download

Related News

arrow-up-right
arrow-up-right